|
GS121575: SK-7041 interacting genes (MeSH:C497103) in CTD
|
|
GS121709: 15-deoxyprostaglandin J2 interacting genes (MeSH:C477819) in CTD
|
|
GS125818: periodate-oxidized adenosine interacting genes (MeSH:C027579) in CTD
|
|
GS195113: GO:0071841 cellular component organization or biogenesis at cellular level
|
|
GS207015: GO:0042592 homeostatic process
|
|
GS199906: GO:0034621 cellular macromolecular complex subunit organization
|
|
GS123554: vinclozolin interacting genes (MeSH:C025643) in CTD
|
|
GS207002: GO:0006336 DNA replication-independent nucleosome assembly
|
|
GS124648: Lipopolysaccharides interacting genes (MeSH:D008070) in CTD
|
|
GS197018: GO:0032993 protein-DNA complex
|
|
GS136891: voluntary alcohol consumption QTL 5 (Vacq5, Published QTL Chr 13)
|
|
GS121818: N-(2-aminophenyl)-4-((4-pyridin-3-ylpyrimidin-2-ylamino)methyl)benzamide interacting genes (MeSH:C523184) in CTD
|
|
GS201949: GO:0044699 single-organism process
|
|
GS36471: Neocortex Gene expression correlates of Morphine - Severity of ptosis in Females BXD
|
|
GS135550: CD4 T cell subset 6 (Cd4ts6, Published QTL Chr 13)
|
|
GS208954: GO:0006139 nucleobase-containing compound metabolic process
|
|
GS123916: Aflatoxin B1 interacting genes (MeSH:D016604) in CTD
|
|
GS195733: GO:0022607 cellular component assembly
|
|
GS125902: benzyloxycarbonylleucyl-leucyl-leucine aldehyde interacting genes (MeSH:C072553) in CTD
|
|
GS121888: methylselenic acid interacting genes (MeSH:C008493) in CTD
|
|
GS121965: Amiodarone interacting genes (MeSH:D000638) in CTD
|
|
GS126475: tert-Butylhydroperoxide interacting genes (MeSH:D020122) in CTD
|
|
GS201656: GO:0045637 regulation of myeloid cell differentiation
|
|
GS197016: GO:0032991 macromolecular complex
|
|
GS123265: Estradiol interacting genes (MeSH:D004958) in CTD
|
|
GS199635: GO:0005622 intracellular
|
|
GS125369: Lamivudine interacting genes (MeSH:D019259) in CTD
|
|
GS195206: GO:0002520 immune system development
|
|
GS136303: modifier of Salmonella typhimurium susceptibility 4 (Msts4, Published QTL Chr 13)
|
|
GS135384: body weight 1 (Bdw1, Published QTL Chr 13)
|
|
GS121976: Zidovudine interacting genes (MeSH:D015215) in CTD
|
|
GS193268: GO:0005575 cellular_component
|
|
GS194039: GO:1901363 heterocyclic compound binding
|
|
GS123377: Glucose interacting genes (MeSH:D005947) in CTD
|
|
GS196934: GO:0065008 regulation of biological quality
|
|
GS125368: Saquinavir interacting genes (MeSH:D019258) in CTD
|
|
GS196943: GO:0008152 metabolic process
|
|
GS125187: Sulindac interacting genes (MeSH:D013467) in CTD
|
|
GS207797: GO:0030154 cell differentiation
|
|
GS127107: Antimony interacting genes (MeSH:D000965) in CTD
|
|
GS207581: GO:0007275 multicellular organismal development
|
|
GS121437: Fluorouracil interacting genes (MeSH:D005472) in CTD
|
|
GS136884: testis weight QTL 1 (Twq1, Published QTL Chr 13)
|
|
GS123332: 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide interacting genes (MeSH:D015123) in CTD
|
|
GS199273: GO:0043233 organelle lumen
|
|
GS122142: Dietary Fats interacting genes (MeSH:D004041) in CTD
|
|
GS196941: GO:0008150 biological_process
|
|
GS136041: insulin dependent diabetes susceptibility 14 (Idd14, Published QTL Chr 13)
|
|
GS205002: GO:0048856 anatomical structure development
|
|
GS199634: GO:0005623 cell
|
|
GS121595: Dexamethasone interacting genes (MeSH:D003907) in CTD
|
|
GS124695: arsenic trioxide interacting genes (MeSH:C006632) in CTD
|
|
GS123595: Progesterone interacting genes (MeSH:D011374) in CTD
|
|
GS121759: Vitamin K 3 interacting genes (MeSH:D024483) in CTD
|
|
GS201256: GO:0044422 organelle part
|
|
GS204007: GO:0044700 single organism signaling
|
|
GS201431: GO:0005515 protein binding
|
|
GS206837: GO:0034728 nucleosome organization
|
|
GS201023: GO:0071704 organic substance metabolic process
|
|
GS126160: Cytarabine interacting genes (MeSH:D003561) in CTD
|
|
GS124165: Hydrogen Peroxide interacting genes (MeSH:D006861) in CTD
|
|
GS194070: GO:0045653 negative regulation of megakaryocyte differentiation
|
|
GS209411: GO:0048869 cellular developmental process
|
|
GS126276: pirinixic acid interacting genes (MeSH:C006253) in CTD
|
|
GS123274: 2,4-diaminotoluene interacting genes (MeSH:C010914) in CTD
|
|
GS205224: GO:0015629 actin cytoskeleton
|
|
GS208893: GO:0005856 cytoskeleton
|
|
GS201251: GO:0044424 intracellular part
|
|
GS195110: GO:0071842 cellular component organization at cellular level
|
|
GS125939: Antimony Potassium Tartrate interacting genes (MeSH:D000966) in CTD
|
|
GS195694: GO:0031055 chromatin remodeling at centromere
|
|
GS84268: nicotine sensitivity (Published QTL, Chr 13)
|
|
GS136029: hypertension (Hypt, Published QTL Chr 13)
|
|
GS209564: GO:0043231 intracellular membrane-bounded organelle
|
|
GS121279: fluticasone interacting genes (MeSH:C065382) in CTD
|
|
GS129100: bone mineral density 3 (Bmd3 Published QTL Chr 13)
|
|
GS199909: GO:0034622 cellular macromolecular complex assembly
|
|
GS196932: GO:0065004 protein-DNA complex assembly
|
|
GS208489: GO:0043044 ATP-dependent chromatin remodeling
|
|
GS126156: (E)-4-((2-N-(4-methoxybenzenesulfonyl)amino)stilbazole)1-oxide interacting genes (MeSH:C479799) in CTD
|
|
GS196988: GO:0045595 regulation of cell differentiation
|
|
GS136606: spacial bias during navigation task 2 (Sbnt2, Published QTL Chr 13)
|
|
GS136469: p-glycoprotein positive CD4 T cell subset 2 (Pcd4ts2, Published QTL Chr 13)
|
|
GS121147: Azacitidine interacting genes (MeSH:D001374) in CTD
|
|
GS125062: palm oil interacting genes (MeSH:C041786) in CTD
|
|
GS199272: GO:0043232 intracellular non-membrane-bounded organelle
|
|
GS209551: GO:0031981 nuclear lumen
|
|
GS136135: lithogenic gene 15 (Lith15, Published QTL Chr 13)
|
|
GS194555: GO:0031974 membrane-enclosed lumen
|
|
GS201649: GO:0045638 negative regulation of myeloid cell differentiation
|
|
GS123943: Curcumin interacting genes (MeSH:D003474) in CTD
|
|
GS121893: Vitamin E interacting genes (MeSH:D014810) in CTD
|
|
GS194524: GO:0006325 chromatin organization
|
|
GS204021: GO:0044707 single-multicellular organism process
|
|
GS205047: GO:0006807 nitrogen compound metabolic process
|
|
GS124579: Selenium interacting genes (MeSH:D012643) in CTD
|
|
GS125578: 3-deazaneplanocin interacting genes (MeSH:C048460) in CTD
|
|
GS195570: GO:0046983 protein dimerization activity
|
|
GS193888: GO:0051276 chromosome organization
|
|
GS200350: GO:0016568 chromatin modification
|
|
GS203335: GO:0048513 organ development
|
|
GS136440: peak bone density 2 (Pbd2, Published QTL Chr 13)
|
|
GS123768: Cyclosporine interacting genes (MeSH:D016572) in CTD
|
|
GS127240: Acetaminophen interacting genes (MeSH:D000082) in CTD
|
|
GS180164: GO:0008150 biological_process
|
|
GS202775: GO:0005694 chromosome
|
|
GS127138: gemcitabine interacting genes (MeSH:C056507) in CTD
|
|
GS201554: GO:0032200 telomere organization
|
|
GS122852: alitretinoin interacting genes (MeSH:C103303) in CTD
|
|
GS198687: GO:0034080 CenH3-containing nucleosome assembly at centromere
|
|
GS196987: GO:0045596 negative regulation of cell differentiation
|
|
GS124226: salmeterol interacting genes (MeSH:C057823) in CTD
|
|
GS125692: 2,3-dimethoxy-1,4-naphthoquinone interacting genes (MeSH:C063002) in CTD
|
|
GS207004: GO:0006334 nucleosome assembly
|
|
GS205255: GO:0044238 primary metabolic process
|
|
GS203283: GO:0071824 protein-DNA complex subunit organization
|
|
GS123048: Tretinoin interacting genes (MeSH:D014212) in CTD
|
|
GS208012: GO:0044464 cell part
|
|
GS136779: systolic blood pressure 2 (Sysbp2, Published QTL Chr 13)
|
|
GS197573: GO:0043486 histone exchange
|
|
GS210212: GO:0005575 cellular_component
|
|
GS201239: GO:0046483 heterocycle metabolic process
|
|
GS122168: irinotecan interacting genes (MeSH:C051890) in CTD
|
|
GS123789: LBH589 interacting genes (MeSH:C496932) in CTD
|
|
GS207006: GO:0006333 chromatin assembly or disassembly
|
|
GS194455: GO:0051239 regulation of multicellular organismal process
|
|
GS206623: GO:0050794 regulation of cellular process
|
|
GS122305: resveratrol interacting genes (MeSH:C059514) in CTD
|
|
GS124805: decitabine interacting genes (MeSH:C014347) in CTD
|
|
GS194284: GO:0048534 hematopoietic or lymphoid organ development
|
|
GS126862: fludarabine interacting genes (MeSH:C024352) in CTD
|
|
GS210514: GO:0048017 inositol lipid-mediated signaling
|
|
GS125506: Valproic Acid interacting genes (MeSH:D014635) in CTD
|
|
GS207000: GO:0006338 chromatin remodeling
|
|
GS196806: GO:0032502 developmental process
|
|
GS206618: GO:0050793 regulation of developmental process
|
|
GS196553: GO:0005730 nucleolus
|
|
GS210214: GO:0005576 extracellular region
|
|
GS210512: GO:0048015 phosphatidylinositol-mediated signaling
|
|
GS203594: GO:0043226 organelle
|
|
GS122390: Indinavir interacting genes (MeSH:D019469) in CTD
|
|
GS200432: GO:0002682 regulation of immune system process
|
|
GS123615: Potassium Dichromate interacting genes (MeSH:D011192) in CTD
|
|
GS198868: GO:0000786 nucleosome
|
|
GS197892: GO:0043228 non-membrane-bounded organelle
|
|
GS195643: GO:0003677 DNA binding
|
|
GS210169: GO:0030099 myeloid cell differentiation
|
|
GS194586: GO:0002376 immune system process
|
|
GS206500: GO:0031497 chromatin assembly
|
|
GS208716: GO:2000026 regulation of multicellular organismal development
|
|
GS209928: GO:0006996 organelle organization
|
|
GS194527: GO:0006323 DNA packaging
|
|
GS196808: GO:0032501 multicellular organismal process
|
|
GS125811: Butyric Acid interacting genes (MeSH:D020148) in CTD
|
|
GS194077: GO:0071103 DNA conformation change
|
|
GS198866: GO:0000785 chromatin
|
|
GS194069: GO:0045652 regulation of megakaryocyte differentiation
|
|
GS126706: Mercury interacting genes (MeSH:D008628) in CTD
|
|
GS203593: GO:0043227 membrane-bounded organelle
|
|
GS125799: Asbestos, Crocidolite interacting genes (MeSH:D017638) in CTD
|
|
GS121120: N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide interacting genes (MeSH:C118739) in CTD
|
|
GS135996: hippocampal weight 3 (Hipp3, Published QTL Chr 13)
|
|
GS202415: GO:0044710 single-organism metabolic process
|
|
GS127127: Benzo(a)pyrene interacting genes (MeSH:D001564) in CTD
|
|
GS206845: GO:0034724 DNA replication-independent nucleosome organization
|
|
GS136221: mandible length 13 (Manln13, Published QTL Chr 13)
|
|
GS210000: GO:0044446 intracellular organelle part
|
|
GS136005: hapatic PMN infiltration 1 (Hpi1, Published QTL Chr 13)
|
|
GS123037: Chlorambucil interacting genes (MeSH:D002699) in CTD
|
|
GS198684: GO:0048523 negative regulation of cellular process
|
|
GS202316: GO:0050789 regulation of biological process
|
|
GS194087: GO:0003674 molecular_function
|
|
GS205331: GO:0051093 negative regulation of developmental process
|
|
GS126885: Chromium interacting genes (MeSH:D002857) in CTD
|
|
GS177356: GO:0003674 molecular_function
|
|
GS203590: GO:0043229 intracellular organelle
|
|
GS194111: GO:0097159 organic cyclic compound binding
|
|
GS84267: nicotine sensitivity (Published QTL, Chr 13)
|
|
GS126634: methoxyacetic acid interacting genes (MeSH:C013598) in CTD
|
|
GS209824: GO:0030219 megakaryocyte differentiation
|
|
GS136931: vertebral trabecular bone trait 15 (Vtbt15, Published QTL Chr 13)
|
|
GS196927: GO:0065003 macromolecular complex assembly
|
|
GS195199: GO:0005634 nucleus
|
|
GS127114: Methylnitronitrosoguanidine interacting genes (MeSH:D008769) in CTD
|
|
GS194307: GO:0016043 cellular component organization
|
|
GS125043: Homocysteine interacting genes (MeSH:D006710) in CTD
|
|
GS126758: Folic Acid interacting genes (MeSH:D005492) in CTD
|
|
GS195108: GO:0071844 cellular component assembly at cellular level
|
|
GS203072: GO:0090304 nucleic acid metabolic process
|
|
GS135976: wound healing/regeneration 3 (Heal3, Published QTL Chr 13)
|
|
GS201253: GO:0044427 chromosomal part
|
|
GS126584: Tetrachlorodibenzodioxin interacting genes (MeSH:D013749) in CTD
|
|
GS203369: GO:0005654 nucleoplasm
|
|
GS195571: GO:0046982 protein heterodimerization activity
|
|
GS129173: pregnancy QTL 3 (Pregq3 Published QTL Chr 13)
|
|
GS199112: GO:0044085 cellular component biogenesis
|
|
GS205543: GO:0070013 intracellular organelle lumen
|
|
GS196930: GO:0065007 biological regulation
|
|
GS124920: Butyrates interacting genes (MeSH:D002087) in CTD
|
|
GS196719: GO:0006259 DNA metabolic process
|
|
GS125090: monomethylarsonous acid interacting genes (MeSH:C406082) in CTD
|
|
GS136341: nicotine induced locomotor activity 7 (Nilac7, Published QTL Chr 13)
|
|
GS195214: GO:0009987 cellular process
|
|
GS210170: GO:0030097 hemopoiesis
|
|
GS195112: GO:0071840 cellular component organization or biogenesis
|
|
GS199124: GO:0051716 cellular response to stimulus
|
|
GS200648: GO:0044260 cellular macromolecule metabolic process
|
|
GS203058: GO:0048519 negative regulation of biological process
|
|
GS201249: GO:0044428 nuclear part
|
|
GS197244: GO:0044237 cellular metabolic process
|
|
GS206657: GO:0043933 macromolecular complex subunit organization
|
|
GS125634: trichostatin A interacting genes (MeSH:C012589) in CTD
|
|
GS203642: GO:0006725 cellular aromatic compound metabolic process
|
|
GS193991: GO:0048731 system development
|
|
GS207776: GO:0060249 anatomical structure homeostasis
|
|
GS207923: GO:0034641 cellular nitrogen compound metabolic process
|
|
GS198263: GO:0005488 binding
|
|
GS127285: nickel chloride interacting genes (MeSH:C022838) in CTD
|
|
GS194040: GO:1901360 organic cyclic compound metabolic process
|
|
GS194088: GO:0003676 nucleic acid binding
|
|
GS206355: GO:0023052 signaling
|
|
GS122944: Dimethyl Sulfoxide interacting genes (MeSH:D004121) in CTD
|
|
GS209199: GO:0007165 signal transduction
|
|
GS124312: sodium arsenite interacting genes (MeSH:C017947) in CTD
|
|
GS195977: GO:0007154 cell communication
|
|
GS125548: Doxorubicin interacting genes (MeSH:D004317) in CTD
|
|
GS194267: GO:0043170 macromolecule metabolic process
|
|
GS198274: GO:0035556 intracellular signal transduction
|
|
GS209863: GO:0050896 response to stimulus
|
|
GS206359: GO:0000723 telomere maintenance
|